The Journal of Korean Diabetes

Opinion
연속혈당측정에서 시간 기반 혈당 지표의 임상적 의미: 김진영; J Korean Diabetes. 2026;27(1):1-4.

With the widespread adoption of CGM (continuous glucose monitoring), glycemic control can now be evaluated across a continuous time axis rather than at isolated time points. This shift has led...

Statement
Time in Tight Range의 임상적 의미와 적용 범위: 진상만; J Korean Diabetes. 2026;27(1):5-10.

Alongside time in range (TIR, 70–180 mg/dL), an established continuous glucose monitoring (CGM) metric, time in tight range (TITR, 70–140 mg/dL) was originally proposed to reflect glucose exposure closer to...

Focused Issue
당뇨병 정밀 의료를 위한 유전체ㆍ다중 오믹스 기반 유형 분류와 인공지능 통합 예측 전략: 윤재승; J Korean Diabetes. 2026;27(1):11-18.

Type 2 diabetes is increasingly recognized as a heterogeneous syndrome rather than a single disease. Clinical phenotype-based clustering, exemplified by the Ahlqvist model, has demonstrated that subgroups defined by simple...

Focused Issue
의료 인공지능의 이론적 토대와 임상적 활용: 김헌성; J Korean Diabetes. 2026;27(1):19-27.

Medical data can be categorized into structured, unstructured, time-series, image/video, and multimodal data, each of which imposes distinct constraints and offers specific opportunities for artificial intelligence (AI) model design, learning...

Focused Issue
당뇨병과 비만 관리의 디지털 치료: 이상열; J Korean Diabetes. 2026;27(1):28-32.

Diabetes and obesity require sustained, behavior-centered management, yet real-world care is constrained by limited visit time, access barriers, and challenges in long-term adherence. Digital therapeutics (DTx.) deliver evidence-based, software-driven interventions...

Information Desk
고령 당뇨병환자의 자기관리 어려움과 간호 전략: 박설; J Korean Diabetes. 2026;27(1):33-36.

As of 2024, the population aged 65 and older accounts for 19.2% of South Korea’s total population. This figure is projected to rise steadily, surpassing 30% in 2036 and 40%...

Information Desk
초가공식품과 당뇨병: 한지윤; J Korean Diabetes. 2026;27(1):37-43.

The worldwide incidence of diabetes mellitus is steadily increasing, largely attributable to environmental changes, including shifts in dietary patterns and food environments. Notably, global consumption of ultra-processed foods (UPFs) has...

Information Desk
건강 관련 사회적 욕구 선별을 위한 공감적 탐색: 임성철; J Korean Diabetes. 2026;27(1):44-49.

While many healthcare professionals and diabetes educators recognize the critical need to screen for and intervene in health-related social needs (HRSNs) among patients with diabetes, the practical implementation of screening...

Current Issue: Volume 27(1); Mar 2026

Opinion

연속혈당측정에서 시간 기반 혈당 지표의 임상적 의미: 김진영; J Korean Diabetes. 2026;27(1):1-4. Published online March 30, 2026; DOI: https://doi.org/10.4093/jkd.2026.27.1.1

Statement

Time in Tight Range의 임상적 의미와 적용 범위: 진상만; J Korean Diabetes. 2026;27(1):5-10. Published online March 30, 2026; DOI: https://doi.org/10.4093/jkd.2026.27.1.5

Focused Issues

당뇨병 정밀 의료를 위한 유전체ㆍ다중 오믹스 기반 유형 분류와 인공지능 통합 예측 전략: 윤재승; J Korean Diabetes. 2026;27(1):11-18. Published online March 30, 2026; DOI: https://doi.org/10.4093/jkd.2026.27.1.11

의료 인공지능의 이론적 토대와 임상적 활용: 김헌성; J Korean Diabetes. 2026;27(1):19-27. Published online March 30, 2026; DOI: https://doi.org/10.4093/jkd.2026.27.1.19

당뇨병과 비만 관리의 디지털 치료: 이상열; J Korean Diabetes. 2026;27(1):28-32. Published online March 30, 2026; DOI: https://doi.org/10.4093/jkd.2026.27.1.28

Information Desks

고령 당뇨병환자의 자기관리 어려움과 간호 전략: 박설; J Korean Diabetes. 2026;27(1):33-36. Published online March 30, 2026; DOI: https://doi.org/10.4093/jkd.2026.27.1.33

초가공식품과 당뇨병: 한지윤; J Korean Diabetes. 2026;27(1):37-43. Published online March 30, 2026; DOI: https://doi.org/10.4093/jkd.2026.27.1.37

건강 관련 사회적 욕구 선별을 위한 공감적 탐색: 임성철; J Korean Diabetes. 2026;27(1):44-49. Published online March 30, 2026; DOI: https://doi.org/10.4093/jkd.2026.27.1.44

Volume 27, No. 1

The Journal of
Korean Diabetes

Print ISSN: 2233-7431
Online ISSN: 2714-0547

MOST VIEWED

7,243	Guidelines for the Use of 2023 Food Exchange Lists for Diabetes Meal Planning
2,638	Utilization of Smart Healthcare for Gestational Diabetes Mellitus Management
1,576	2025 Clinical Practice Guidelines for Diabetes: Pharmacological Treatment of Type 2 Diabetes
3,177	Diabetes and Dietary Proteins-Protein Supplement Intake
3,685	GLP-1/GIP Receptor Agonists: Mechanism of Action of Tirzepatide

Editorial Office: 101-2104, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-714-9064 Fax: +82-2-714-9084 E-mail: diabetes@kams.or.kr

Copyright © 2026 by Korean Diabetes Association. All rights reserved.

prev

next